Coherus Oncology Inc (CHRS)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

CHRS logo

CHRS Deferred Revenue

Latest reported$0.00
CHRS Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

CHRS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,817,000
0
1,070,000
1,739,000
1,962,000
2,527,000
62,458,000
50,603,000
50,951,000
28,848,000
31,005,000
23,992,000
23,992,000
25,176,000
25,132,000
0
14,283,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.